{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:06:14Z","timestamp":1784077574611,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jpeds.2017.06.076","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T13:15:36Z","timestamp":1504703736000},"page":"21-26.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Everolimus for the Treatment of Tuberous Sclerosis Complex\u2013Related Cardiac Rhabdomyomas in Pediatric Patients"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7715-3169","authenticated-orcid":false,"given":"Nagib","family":"Dahdah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2017.06.076_bib0010","first-page":"CS21","article-title":"Cardiac rhabdomyoma with long-term conduction abnormality: progression from pre-excitation to bundle branch block and finally complete heart block","volume":"13","author":"De Wilde","year":"2007","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00246-003-0590-4","article-title":"Fetal and neonatal cardiac tumors","volume":"25","author":"Isaacs","year":"2004","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0020","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1067\/S0022-3476(03)00494-3","article-title":"Fetal rhabdomyoma: prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex","volume":"143","author":"Bader","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-2-11","article-title":"Cardiac tumours in children","volume":"2","author":"Uzun","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0030","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1542\/peds.2011-3476","article-title":"Everolimus: a challenging drug in the treatment of multifocal inoperable cardiac rhabdomyoma","volume":"130","author":"Demir","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1042\/BJ20080281","article-title":"The TSC1-TSC2 complex: a molecular switchboard controlling cell growth","volume":"412","author":"Huang","year":"2008","journal-title":"Biochem J"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0045","doi-asserted-by":"crossref","first-page":"e1335","DOI":"10.1542\/peds.2010-2910","article-title":"Regression of a cardiac rhabdomyoma in a patient receiving everolimus","volume":"127","author":"Tiberio","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0050","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/adc.68.3.367","article-title":"Cardiac rhabdomyomas and their association with tuberous sclerosis","volume":"68","author":"Webb","year":"1993","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0055","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/sj.ejhg.5201412","article-title":"TSC1, TSC2, TSC3? Or mosaicism?","volume":"13","author":"Kwiatkowski","year":"2005","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0060","doi-asserted-by":"crossref","first-page":"e1146","DOI":"10.1542\/peds.2006-0504","article-title":"Clinical and genotype studies of cardiac tumors in 154 patients with tuberous sclerosis complex","volume":"118","author":"Kotulska","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0065","doi-asserted-by":"crossref","first-page":"e001493","DOI":"10.1161\/JAHA.114.001493","article-title":"Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group","volume":"3","author":"Hinton","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0070","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0075","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0003-4975(98)00180-5","article-title":"Cardiac rhabdomyomas and obstructive left heart disease: histologically but not functionally benign","volume":"65","author":"Black","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0080","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0002-9149(99)80117-9","article-title":"Tuberous sclerosis and cardiac rhabdomyoma","volume":"76","author":"Nir","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0085","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1055\/s-0029-1223267","article-title":"Perinatal (fetal and neonatal) tuberous sclerosis: a review","volume":"26","author":"Isaacs","year":"2009","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0090","doi-asserted-by":"crossref","unstructured":"Aw F., Leye M., Major P., Gagnon H., Briere J., Dahdah N. Arrhythmias and functional disorders in 43 patients with tuberous sclerosis. Presented at International TSC Research Conference. September 10-12, 2015, Windsor, UK.","DOI":"10.1016\/j.cjca.2015.07.081"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/uog.5264","article-title":"Outcome of antenatally diagnosed cardiac rhabdomyoma: case series and a meta-analysis","volume":"31","author":"Chao","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0100","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1651-2227.1996.tb14188.x","article-title":"The natural history of cardiac rhabdomyoma with and without tuberous sclerosis","volume":"85","author":"Bosi","year":"1996","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0105","first-page":"8712962","article-title":"Regression of cardiac rhabdomyomas in a neonate after everolimus treatment","volume":"2016","author":"Bornaun","year":"2016","journal-title":"Case Rep Pediatr"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0110","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00059-014-4078-1","article-title":"Cardiac rhabdomyomas associated with tuberous sclerosis complex in children. From presentation to outcome","volume":"40","author":"Shen","year":"2015","journal-title":"Herz"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0115","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0025-6196(12)61196-3","article-title":"Causes of death in patients with tuberous sclerosis","volume":"66","author":"Shepherd","year":"1991","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0120","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1468-1331.2009.02567.x","article-title":"Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature","volume":"16","author":"Adriaensen","year":"2009","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0125","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1212\/01.WNL.0000142039.14522.1A","article-title":"Subependymal giant cell tumors in tuberous sclerosis complex","volume":"63","author":"Goh","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0130","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"Franz","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1053\/j.ajkd.2011.10.013","article-title":"Tuberous sclerosis complex-associated angiomyolipomas: focus on mTOR inhibition","volume":"59","author":"Budde","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0145","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023379","article-title":"Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF-D levels decrease","volume":"6","author":"Dabora","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0155","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0160","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00381-011-1406-0","article-title":"The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective","volume":"27","author":"Moavero","year":"2011","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0165","series-title":"Evaluation of angiomyolipoma tumor behavior after termination of everolimus treatment: results of a subanalysis from EXIST-2","author":"Bissler","year":"2016"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0170","series-title":"Afinitor tablets for oral administration, Afinitor Disperz tablets for oral suspension [package insert]","year":"2016"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0175","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00246-016-1528-y","article-title":"Accelerated cardiac rhabdomyoma regression with everolimus in infants with tuberous sclerosis complex","volume":"38","author":"Aw","year":"2017","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0180","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-212946","article-title":"Rapid resolution of cardiac rhabdomyomas following everolimus therapy","volume":"2015","author":"Choudhry","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0185","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1017\/S1047951116000421","article-title":"Everolimus-induced near-resolution of giant cardiac rhabdomyomas and large renal angiomyolipoma in a newborn with tuberous sclerosis complex","volume":"26","author":"Colaneri","year":"2016","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0190","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/tropej\/fmu056","article-title":"Regression of symptomatic multiple cardiac rhabdomyomas associated with tuberous sclerosis complex in a newborn receiving everolimus","volume":"61","author":"Do\u011fan","year":"2015","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0195","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.pediatrneurol.2015.01.004","article-title":"Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex","volume":"52","author":"Goyer","year":"2015","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0200","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/ped.12816","article-title":"Regression of massive cardiac rhabdomyoma on everolimus therapy","volume":"58","author":"Hoshal","year":"2016","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0205","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/08880018.2012.734896","article-title":"Cardiac rhabdomyomas associated with tuberous sclerosis complex in 11 children: presentation to outcome","volume":"30","author":"Kocaba\u015f","year":"2013","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0210","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/uog.13434","article-title":"Prenatal diagnosis of giant cardiac rhabdomyoma in tuberous sclerosis complex: a new therapeutic option with everolimus","volume":"45","author":"Mlczoch","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0215","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-205138","article-title":"Oral everolimus treatment in a preterm infant with multifocal inoperable cardiac rhabdomyoma associated with tuberous sclerosis complex and a structural heart defect","volume":"2014","author":"Mohamed","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0220","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1017\/S1047951114002261","article-title":"Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia","volume":"25","author":"\u00d6ztun\u00e7","year":"2015","journal-title":"Cardiol Young"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0225","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/echo.13015","article-title":"Oral everolimus for treatment of a giant left ventricular rhabdomyoma in a neonate-rapid tumor regression documented by real time 3D echocardiography","volume":"32","author":"Wagner","year":"2015","journal-title":"Echocardiography"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2350\/06-11-0191.1","article-title":"Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities","volume":"12","author":"Kotulska","year":"2009","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0235","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.tem.2010.05.003","article-title":"Energy balance and puberty onset: emerging role of central mTOR signaling","volume":"21","author":"Roa","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0240","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1210\/en.2009-0096","article-title":"The mammalian target of rapamycin as novel central regulator of puberty onset via modulation of hypothalamic Kiss1 system","volume":"150","author":"Roa","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0245","series-title":"Pooled analysis of menstrual irregularities from 3 major clinical studies evaluating everolimus for the treatment of tuberous sclerosis complex [abstract]","author":"Sparagana","year":"2016"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0250","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00467-013-2459-y","article-title":"Long-term side effects of treatment with mTOR inhibitors in children after renal transplantation","volume":"28","author":"Kranz","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0255","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/j.1600-6143.2010.03266.x","article-title":"De novo therapy with everolimus, low-dose ciclosporine A, basiliximab and steroid elimination in pediatric kidney transplantation","volume":"10","author":"Pape","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0260","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1432-2277.2006.00423.x","article-title":"Gonadal impact of target of rapamycin inhibitors (sirolimus and everolimus) in male patients: an overview","volume":"20","author":"Huyghe","year":"2007","journal-title":"Transpl Int"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0265","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2011.08.005","article-title":"Cardiac tumors and associated arrhythmias in pediatric patients, with observations on surgical therapy for ventricular tachycardia","volume":"58","author":"Miyake","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jpeds.2017.06.076_bib0270","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-3476(87)80539-5","article-title":"Surgical treatment of pediatric cardiac arrhythmia","volume":"110","author":"Campbell","year":"1987","journal-title":"J Pediatr"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347617309265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347617309265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T16:05:55Z","timestamp":1750867555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347617309265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":53,"alternative-id":["S0022347617309265"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2017.06.076","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Everolimus for the Treatment of Tuberous Sclerosis Complex\u2013Related Cardiac Rhabdomyomas in Pediatric Patients","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2017.06.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}